A £12.8bn Reason To Sell Barclays PLC Today

Barclays PLC (LON:BARC) plan to raise £12.8bn could have disappointing side effects, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Barclays (LSE: BARC) (NYSE: BCS.US) may have avoided a government bailout during the financial crisis, but it didn’t escape unscathed from the Prudential Regulation Authority’s recent capital adequacy review, which found that Barclays had a £12.8bn capital shortfall.

Barclays immediately announced a package of measure to address the problem. The firm’s plan for a £5.8bn rights issue has grabbed most of the headlines, but I reckon that the devil is in the details, and that now might be a good time to sell Barclays shares.

Where to find a spare £12.8bn?

Barclays needs to find an extra £12.8bn by June 2014, and has a clear plan for achieving this. We already know that £5.8bn is going to come from a rights issue, but what about the rest?

According to Barclays’ plan, the remaining £7bn is going to come from a combination of reduced leverage on the bank’s own investments, retaining more of its earnings, and issuing £2bn of contingent convertible bonds. Known as ‘CoCos’, these special bonds can have their interest payments suspended at will, and can be converted into shares if the bank’s capital ratio falls below a certain level — effectively writing off the debt.

It’s not a bad plan, and should leave Barclays with a much stronger, safer balance sheet, but I’m not convinced that it’s a very appealing prospect for investors.

Stagnant returns

By June next year, Barclays should have another £12.8bn of capital on its balance sheet, but it won’t be able to do much with it. As the bank commented in its leverage plan, it will have a “limited ability to deploy the capital raised … in higher return areas”.

Barclays’ problem is that the definition of regulatory capital is pretty narrow, and basically means either cash equivalents or government bonds, neither of which generate very high returns.

I suspect that Barclays is going to struggle to grow or even maintain its earnings over the next year or two. An increase in retained earnings means that the bank will be almost entirely dependent on its investment banking division to generate increased profits — a risky strategy.

Barclays has trumpeted its plan to increase dividend payouts to 40-50% of earnings by 2014, a year earlier than originally planned, but I think that this may be an attempt to disguise the fact that the bank’s earnings are likely to be fairly uninspiring in the near-term future.

An alternative to Barclays

Barclays shares are up 53% so far this year, and if you’ve already cashed in, then you may be interested to learn about the Motley Fool’s latest recommendation for growth investors.

The Fool’s analysts have named the share The Top Growth Share For Today“. The firm’s earnings per share have risen by almost 50% since 2008, and the report explains why the company could be seriously undervalued.

If you’d like to learn more about this fast-growing firm, then click here to download the Fool’s exclusive free report, which will only be available for a limited period.

> Roland does not own shares in any of the companies mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »